Caverject Impulse

See also: Generic Caverject

Caverject Impulse is a brand name of alprostadil, approved by the FDA in the following formulation(s):

CAVERJECT IMPULSE (alprostadil - injectable; injection)

• 
  Manufacturer: PHARMACIA AND UPJOHN
  
  Approval date: June 11, 2002
  
  Strength(s): 0.01MG/VIAL, 0.02MG/VIAL
  

Has a generic version of Caverject Impulse been approved?

No. There is currently no therapeutically equivalent version of Caverject Impulse available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Caverject Impulse. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Injection cartridge
  Patent 5,501,673
  Issued: March 26, 1996
  Inventor(s): Hjertman; Birger & Levander; Gustav & Ljunquist; Olle
  Assignee(s): Pharmacia AB
  An injection cartridge of the dual-chamber type has a bypass connection between its two chambers which is arranged such that the interior wall of the cartridge is modified in a determined area in such a way that the movable wall between the two chambers does not seal completely against the interior wall in said area.
  
  Patent expiration dates:
  
  
  • April 16, 2013
    
    ✓ 
    Drug product
  
  



• 
  Dual-chamber type injection cartridge with bypass connection
  Patent 5,716,338
  Issued: February 10, 1998
  Inventor(s): Hjertman; Birger & Pavlu; Bohdan
  Assignee(s): Pharmacia & Upjohn Aktiebolag
  An injection cartridge (1) of the dual-chamber type having a bypass connection (12) between its two chambers (9, 10) which is arranged such that the interior wall of the cartridge is modified in a predetermined area in such a way that the movable wall (11) between the two chambers does not seal completely against the interior wall in said area. The modification of the wall is arranged as a plurality of lands and grooves (12) which have a direction that is inclined in relation to the longitudinal axis of the cartridge barrel.
  
  Patent expiration dates:
  
  
  • February 10, 2015
    
    ✓ 
    Drug product
  
  

See also...

• Caverject Impulse Consumer Information (Wolters Kluwer)
• Caverject Impulse injectable and transurethral Consumer Information (Cerner Multum)
• Alprostadil Consumer Information (Wolters Kluwer)
• Alprostadil Suppository Consumer Information (Wolters Kluwer)
• Alprostadil injectable and transurethral Consumer Information (Cerner Multum)
• Muse Micro Advanced Consumer Information (Micromedex)
• Alprostadil Intraurethral, Intravenous, Intracavernosal Advanced Consumer Information (Micromedex)
• Alprostadil AHFS DI Monographs (ASHP)